Past Trade & Access to Medicines Work
- Sign the Organizational Sign-on Letter in Support of Brazilian Patent Law Reform
- Read the blog by Health GAP Senior Policy Analyst, Brook Baker denouncing a letter by members of Congress criticizing India's patent laws.
- Download the dangerous and depressing letter from 170 Congressmembers criticizing India Patent law and supporting big PhRMA.
- Download the press release regarding the TRIPS Council decision on Least Developed Countries and access to medicines.
- Read the blog by Health GAP Senior Policy Analyst, Brook Baker about the WTO TRIPS Council decision to extend Least Developed Country status and it's impact on access to medicines.
- Download the letter to the WTO TRIPS Council regarding the Least Developed Country Extension signed by dozens of leading academics from around the world.
- Read the blog by Health GAP Senior Policy Analyst, Brook Baker On the heels of Novartis victory taming evergreening of patents on medicines, European Investment Clause proposals in EU-India FTA threaten to undo all gains
- Download the press release announcing the decision of the Indian Supreme Court to dismiss the case brought by Novartis in their attempt to "evergreen" their patent
- Read a short analysis of the Indian Supreme Court Novartis Case
- Download the fact sheet on Least Developed Country (LDC) Extension
- Download the letter from 375 Civil Society Orgs Urging the WTO to extend the time that LDCs to convert to environmentally sound technologies
- Download Health GAP's press statement on the the agreement between ViiV and Medicines Patent Pool for pediatric AIDS drug